1. Home
  2. VTRS vs RGA Comparison

VTRS vs RGA Comparison

Compare VTRS & RGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

SELL

Current Price

$17.56

Market Cap

18.7B

Sector

Health Care

ML Signal

SELL

Logo Reinsurance Group of America Incorporated

RGA

Reinsurance Group of America Incorporated

SELL

Current Price

$250.89

Market Cap

16.3B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
VTRS
RGA
Founded
1961
1973
Country
United States
United States
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
16.3B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
VTRS
RGA
Price
$17.56
$250.89
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$19.40
★ $277.33
AVG Volume (30 Days)
★ 7.3M
272.9K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
★ 2.72%
1.56%
EPS Growth
N/A
★ 64.86
EPS
0.05
★ 11.99
Revenue
$14,299,900,000.00
★ $23,698,000,000.00
Revenue This Year
$3.42
$13.98
Revenue Next Year
$1.68
$4.59
P/E Ratio
$351.50
★ $20.90
Revenue Growth
N/A
★ 7.20
52 Week Low
$9.69
$178.21
52 Week High
$18.43
$257.81

Technical Indicators

Market Signals
Indicator
VTRS
RGA
Relative Strength Index (RSI) 56.26 56.56
Support Level $15.94 $241.85
Resistance Level $18.23 $254.89
Average True Range (ATR) 0.47 5.04
MACD 0.03 -0.01
Stochastic Oscillator 50.14 66.50

Price Performance

Historical Comparison
VTRS
RGA

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About RGA Reinsurance Group of America Incorporated

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

Share on Social Networks: